SCHEMBL7141050

SCHEMBL7141050

CC(C)(C)OC(=O)Nc1cc(OC(C)(C)C)c(-c2ccccc2F)cc1NC(=O)CC(=O)c1ccnc(C#N)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.35
DHODH Q02127 2/20 0.33
PARP14 Q460N5 1/20 0.33
EGLN2 Q96KS0 2/20 0.33
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
AAK1 Q2M2I8 4/20 0.32
PTPN1 P18031 1/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
BRD4 O60885 1/20 0.31
KCNQ4 P56696 1/20 0.31
KCNQ5 Q9NR82 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140010 0.94 MEN1 (0.36) CYP17A1DHODHPARP14EGLN2MEN1
SCHEMBL7704536 0.92 DHODH (0.36) DHODHPARP14MEN1MAPTKMT2A
SCHEMBL7145193 0.88 CYP17A1 (0.37) CYP17A1EGLN2AAK1KCNQ4KCNQ5
SCHEMBL5868818 0.87 CYP17A1 (0.41) CYP17A1PARP14EGLN2CTSSCTSK
SCHEMBL7145960 0.86 EGLN2 (0.36) DHODHEGLN2CTSSCTSKMEN1
SCHEMBL7143926 0.81 DHODH (0.34) DHODHEGLN2CTSSCTSKBRD4
SCHEMBL7143172 0.80 GAA (0.38) DHODHEGLN2CTSSCTSKMEN1
SCHEMBL7139979 0.80 ALDH1A1 (0.40) EGLN2MEN1MAPTKMT2AALDH1A1
SCHEMBL7146199 0.79 ALDH1A1 (0.38) MEN1MAPTKMT2AALDH1A1SMN1; SMN2
SCHEMBL6434527 0.79 AAK1 (0.38) AAK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed